Search Results - "Koval, Stephen"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study by Sharma, Arya M, Davidson, Jaime, Koval, Stephen, Lacourcière, Yves

    Published in Cardiovascular diabetology (02-10-2007)
    “…The Study of Micardis (telmisartan) in Overweight/Obese patients with Type 2 diabetes and Hypertension (SMOOTH) compared hydrochlorothiazide (HCTZ) plus…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial by White, William B, Murwin, Debra, Chrysant, Steven G, Koval, Stephen E, Davidai, Giora, Guthrie, Robert

    Published in Blood pressure monitoring (01-02-2008)
    “…In 2004-2005, the antihypertensive effects of telmisartan 80 mg versus valsartan 160 mg combined with hydrochlorothiazide 25 mg were assessed in a large…”
    Get full text
    Journal Article
  4. 4

    Effects of the Angiotensin II Receptor Blockers Telmisartan vs Valsartan in Combination With Hydrochlorothiazide 25 mg Once Daily for the Treatment of Hypertension by White, William B., Punzi, Henry A., Murwin, Debra, Koval, Stephen E., Davidai, Giora, Neutel, Joel M.

    “…To attain recent goals of blood pressure (BP) control, multiple drug therapy combinations are required, including higher doses of thiazide diuretics in…”
    Get full text
    Journal Article
  5. 5

    Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy by Bakris, George, Burgess, Ellen, Weir, Matthew, Davidai, Giora, Koval, Stephen

    Published in Kidney international (01-08-2008)
    “…In patients with diabetic nephropathy, lowering blood pressure and reducing proteinuria by over 30% correlates with a slower progression to kidney failure. We…”
    Get full text
    Journal Article
  6. 6

    A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome by Kurlan, Roger, Crespi, Giovanna, Coffey, Barbara, Mueller-Vahl, Kirsten, Koval, Stephen, Wunderlich, Glen

    Published in Movement disorders (01-05-2012)
    “…Background: Dopamine agonists could theoretically normalize the suspected central dopamine hypersensitivity in Tourette's syndrome. Methods: There was a…”
    Get full text
    Journal Article
  7. 7

    Comparison of telmisartan versus losartan: meta-analysis of titration-to-response studies by Smith, David H G, Cramer, Maarten-Jan M, Neutel, Joel M, Hettiarachchi, Rohan, Koval, Stephen

    Published in Blood pressure monitoring (01-06-2003)
    “…To compare the ability of telmisartan and losartan to reduce mean diastolic blood pressure (DBP) during the last 6 h of the 24-h dosing interval in a…”
    Get full text
    Journal Article